• LAST PRICE
    20.9000
  • TODAY'S CHANGE (%)
    Trending Up0.5100 (2.5012%)
  • Bid / Lots
    20.3000/ 1
  • Ask / Lots
    21.3200/ 2
  • Open / Previous Close
    20.4500 / 20.3900
  • Day Range
    Low 20.3300
    High 21.0400
  • 52 Week Range
    Low 16.2100
    High 37.8800
  • Volume
    171,650
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 20.39
TimeVolumeITOS
09:32 ET115220.33
09:33 ET30020.8
09:37 ET57020.54
09:42 ET10020.56
09:46 ET10020.675
09:50 ET20020.72
09:53 ET40020.85
09:55 ET10020.85
09:57 ET141220.8
10:09 ET10020.74
10:13 ET10020.77
10:18 ET327820.825
10:20 ET485520.75
10:27 ET10020.86
10:33 ET34420.85
10:36 ET30020.855
10:38 ET73520.9214
10:42 ET20020.855
10:45 ET20020.89
10:47 ET10020.94
10:49 ET10020.89
10:51 ET10020.955
10:54 ET10020.83
11:00 ET10020.875
11:02 ET10020.93
11:07 ET208920.93
11:12 ET10020.965
11:14 ET20020.96
11:21 ET130820.94
11:23 ET30021.01
11:27 ET70020.9297
11:30 ET20020.94
11:34 ET10020.91
11:36 ET650020.85
11:38 ET10021.015
11:41 ET50020.95
11:43 ET20020.965
11:45 ET10020.83
11:48 ET10020.965
11:54 ET10020.84
11:57 ET130020.83
11:59 ET20020.795
12:03 ET10020.76
12:06 ET22620.76
12:08 ET50020.78
12:14 ET64020.78
12:15 ET10020.855
12:19 ET10020.795
12:42 ET60020.87
12:44 ET10020.965
12:51 ET100020.845
12:53 ET50020.76
12:57 ET20020.76
01:06 ET10020.815
01:08 ET110020.9
01:11 ET20020.93
01:29 ET134220.98
01:38 ET10021.03
01:40 ET20020.94
01:42 ET21420.97
01:44 ET70020.95
01:47 ET188120.93
01:51 ET10020.93
01:54 ET233020.89
01:56 ET20020.93
01:58 ET25020.8576
02:02 ET20020.84
02:09 ET60020.82
02:12 ET10020.84
02:18 ET50020.86
02:20 ET80020.815
02:21 ET50020.86
02:23 ET65020.85
02:32 ET10020.81
02:36 ET130020.78
02:41 ET129120.78
02:43 ET50020.7301
02:52 ET50020.82
02:54 ET10020.86
03:01 ET10020.9
03:03 ET90020.79
03:10 ET10020.73
03:12 ET10020.76
03:14 ET10020.795
03:17 ET30020.74
03:19 ET30020.72
03:21 ET41020.69
03:32 ET10020.71
03:33 ET10020.71
03:37 ET70020.69
03:39 ET20020.66
03:44 ET10020.65
03:46 ET111020.62
03:48 ET80020.66
03:50 ET25520.64
03:51 ET178820.8
03:53 ET30020.81
03:55 ET71720.81
03:57 ET201320.86
04:00 ET607320.9
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesITOS
Iteos Therapeutics Inc
725.4M
3.1x
---
United StatesICPT
Intercept Pharmaceuticals Inc
743.0M
-3.0x
---
United StatesCHRS
Coherus BioSciences Inc
633.1M
-2.4x
---
United StatesAGEN
Agenus Inc
722.1M
-3.3x
---
United StatesCDNA
CareDx Inc
784.3M
-10.7x
---
United StatesAVIR
Atea Pharmaceuticals Inc
384.0M
12.9x
---
As of 2023-01-31

Company Information

iTeos Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of differentiated immuno-oncology therapeutics for patients with cancer. The Company's pipeline includes two clinical-stage programs: EOS-448 and Inupadenant. The Company’s lead antibody product candidate, EOS-448, is an antagonist of T-cell immunoreceptor with Ig and ITIM domains (TIGIT), an immune checkpoint with multiple mechanisms of action, which leads to immunosuppression. Its inupadenant, is an adenosine A2A receptor antagonist tailored to overcome the specific adenosine-mediated immunosuppression found in tumor microenvironment. The Company is conducting an open-label multi-arm Phase I/IIa clinical trial of inupadenant in adult cancer patients with advanced solid tumors.

Contact Information

Headquarters
321 Arsenal Street Bldg 312, Floor 3, Suite 301WATERTOWN, MA, United States 02472
Phone
857-204-4583
Fax
302-655-5049

Executives

Non-Executive Independent Chairman of the Board
David Hallal
Chief Executive Officer, Director
Michel Detheux
Chief Financial Officer
Matthew Gall
Chief Operating Officer
Matthew Call
Chief Scientific Officer
Yvonne Mcgrath

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$725.4M
Revenue (TTM)
$454.2M
Shares Outstanding
35.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$6.80
Book Value
$15.59
P/E Ratio
3.1x
Price/Sales (TTM)
1.6
Price/Cash Flow (TTM)
2.8x
Operating Margin
70.99%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.